Look for:

Our offer for

EVOTEC AG


ISIN:
DE0005664809
WKN:
566480

2023/05/09 18:00:00
Price
16.024 CHF
Difference 1.34% (0.21)

General attributes

ISINDE0005664809
SymbolEVT
ExchangeBX Swiss
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)3,604 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)19.785 CHF (4,006)
Ask (Ask size)19.813 CHF (4,006)
Open16.024 CHF
High16.024 CHF
Low16.024 CHF
Close (prev. day)15.812 CHF
VWAP16.024 CHF
Volume (pcs)750
Trading volume12,018.00
Number of trades1
Last size750

Futures and Options

Related Futures23
Related Options-

PDF Downloads

Annual report: EVOTEC AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/05/09 18:00:00
Price
16.024 CHF
Difference 1.34% (0.21)

General attributes

ISINDE0005664809
SymbolEVT
ExchangeBX Swiss
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)3,604 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)19.785 CHF (4,006)
Ask (Ask size)19.813 CHF (4,006)
Open16.024 CHF
High16.024 CHF
Low16.024 CHF
Close (prev. day)15.812 CHF
VWAP16.024 CHF
Volume (pcs)750
Trading volume12,018.00
Number of trades1
Last size750

Performance and Risk

6M1Y3Y
Perf (%)---
Perf (abs.)---
Beta1.091.150.82
Volatility163.61163.61163.61
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)17.191 CHF (467)
Ø price 30 days | Ø volume 30 days (pcs.)- CHF (414)
Ø price 100 days | Ø volume 100 days (pcs.)- CHF (414)
Ø price 250 days | Ø volume 250 days (pcs.)- CHF (414)
YTD High | date18.856 CHF (2023/01/26)
YTD Low | date15.812 CHF (2023/05/08)
52 Weeks High | date18.856 CHF (2023/01/26)
52 Weeks Low | date15.812 CHF (2023/05/08)

All listings for EVOTEC AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/05/2617:3620.37 EUR4.051,025
Vienna Stock Exchange2023/05/2617:3220.35 EUR0.003
Tradegate2023/05/2622:2620.37 EUR0.54109
Stuttgart2023/05/2621:5520.29 EUR0.0257
SIX Swiss Exchange2023/04/1217:3527.76 CHF0.001
Munich2023/05/2608:0120.11 EUR0.001
London Stock Exchange European Trade Reporting2023/05/2617:3020.4125 EUR0.002
Hanover2023/05/2608:1620.21 EUR0.001
Hamburg2023/05/2616:4420.31 EUR0.002
Frankfurt2023/05/2621:4220.27 EUR0.013
FINRA other OTC Issues2023/05/1016:2020.85 USD0.002
Duesseldorf2023/05/2615:1320.20 EUR0.002
Berlin2023/05/2621:5220.35 EUR0.0017
BX Swiss2023/05/0918:0016.024 CHF0.011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1286&ID_TYPE_IMAGE_LOGO=2

Contact Details

EVOTEC SE
- -
Manfred Eigen Campus, Essener Bogen 7 - 22419 Hamburg
Telefon: +49-40-56081-0
Fax: +49-40-56081-222
E-mail: info@evotec.com

PDF Downloads

Annual report: EVOTEC AGPDF Download

Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Members of Management Board

Werner LanthalerChairman of Managing Board
Cord DohrmannMember of Executive Committee
Craig JohnstoneMember of Executive Committee
Enno SpillnerMember of Executive Committee

Board of directors

Iris Löw-FriedrichChairman of Supervisory Board
Constanze Ulmer-EilfortMember of Supervisory Board
Elaine SullivanMember of Supervisory Board
Mario PolywkaMember of Supervisory Board
Camilla LanguilleMember of Supervisory Board
Roland SackersMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.